Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Accepted on 03 Apr 2025

Pathological Complete Response after Monotherapy with Immune Checkpoint Inhibitors for Bifocal Colon Cancer in a Patient with Lynch syndrome And Situs Inversus Totalis: A Case Report

in Cancer Immunity and Immunotherapy

Jun Feng
Wenbo Niu
Juan Zhang
Yuanyi Ding
Zheng Li
Zhang Jianfeng
Baokun Li
Chenhui Li
Wang Feifei
Guiying Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571607

Review

Accepted on 03 Apr 2025

From Neglect to Necessity: The Role of Innate Immunity in Cutaneous Squamous Cell Carcinoma Therapy

in Cancer Immunity and Immunotherapy

Yong He
Ting Tian
Yuancheng Li
Xiaoke Wang
Leqi Qian
Tian Tian
Mingjun Jiang
Liming Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1570032

Case Report

Accepted on 03 Apr 2025

Intrathecal administration of PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from breast cancer: a case report

in Cancer Immunity and Immunotherapy

Zhenyu Pan
Yushan Huang
Miaomiao Liu
Panpan Tai
Xiao Chen
Min Liu
Guozi Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1567324

Correction

Accepted on 03 Apr 2025

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment

in Cancer Immunity and Immunotherapy

Victoria A Jennings
Graham P Cook
Fiona Errington-Mais

Frontiers in Immunology

doi 10.3389/fimmu.2025.1601201

Systematic Review

Accepted on 03 Apr 2025

Bispecific Antibodies Combined with Chemotherapy in Solid Tumor Treatment, the Path Forward?

in Cancer Immunity and Immunotherapy

Yici Yan
Jing Yuan
Yanyang Peng
Chenxi Zhou
Xinbo Liu
Leitao Sun
Qiaoling Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1568724

Original Research

Published on 03 Apr 2025

Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study

in Cancer Immunity and Immunotherapy

Koki Oyama
Kohei Nakata
Toshiya Abe
Kento Hirotaka
Nao Fujimori
Kazuma Kiyotani
Chika Iwamoto
Naoki Ikenaga
Shinji Morisaki
Masayo Umebayashi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571182

236 views

Systematic Review

Published on 03 Apr 2025

Pulmonary fibrosis complicated by lung cancer: bibliometric analysis from 2004 to 2024 - research status, trends and future directions

in Cancer Immunity and Immunotherapy

Boyang Li
Fan Wu
Xinlai Ma
Weishan Yuan
Jiaqing Li
Wei Zhang
Xue Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514831

280 views

Original Research

Published on 03 Apr 2025

Cuproptosis-related gene ACAD8 inhibits the metastatic ability of colorectal cancer by inducing cuproptosis

in Cancer Immunity and Immunotherapy

HuiE Zhuang
Yizhen Chen
Sifu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560322

193 views

Review

Published on 03 Apr 2025

Benign non-immune cells in tumor microenvironment

in Cancer Immunity and Immunotherapy

Shaowen Liu
Chunhui Liu
Yuan He
Jun Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561577

207 views

Review

Published on 03 Apr 2025

The role of autophagy in cancer: from molecular mechanism to therapeutic window

in Cancer Immunity and Immunotherapy

Pooya Jalali
Arvin Shahmoradi
Amir Samii
Radman Mazloomnejad
Mohammad Reza Hatamnejad
Anwaar Saeed
Afshin Namdar
Zahra Salehi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528230

376 views

Original Research

Published on 03 Apr 2025

Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial

in Cancer Immunity and Immunotherapy

Brigit van Dijk
Ivonne J. H. Schoenaker
Astrid A. M. van der Veldt
Jan Willem B. de Groot

Frontiers in Immunology

doi 10.3389/fimmu.2025.1564463

164 views

Methods

Published on 03 Apr 2025

Nucleofection-based screening of chimeric antigen receptor candidates in human natural killer cells

in Cancer Immunity and Immunotherapy

Chelsia Qiuxia Wang
Leonard Leong
Lei Yang
Shengli Xu
Kong-Peng Lam
Andre Boon-Hwa Choo
Andy Hee-Meng Tan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557766

326 views

Original Research

Published on 03 Apr 2025

Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis

in Cancer Immunity and Immunotherapy

Zuojuan Xiang
Zhengxiong Li
Xiaojuan Chen
Yingzhou Fu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562875

258 views

Mini Review

Accepted on 02 Apr 2025

Dendritic Cells in Multiple Myeloma: From Immune Evasion to Therapeutic Potential

in Cancer Immunity and Immunotherapy

Melanie Andrea Jordan
Johannes Morschl
Stella E Autenrieth

Frontiers in Immunology

doi 10.3389/fimmu.2025.1575509

Review

Accepted on 02 Apr 2025

Role and Mechanisms of Exercise Therapy in Enhancing Drug Treatment for Glioma: A Review

in Cancer Immunity and Immunotherapy

Guanghui Wu
Yisheng Chen
Chong Chen
Jianling Liu
Qiaowu Wu
Yazhen Zhang
Runqiong Chen
Jianzhong Xiao
Yusheng Su
Haojun Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1576283

Review

Accepted on 02 Apr 2025

Long non-coding RNAs as Key Modulators of the Immune Microenvironment in Hepatocellular Carcinoma: Implications for Immunotherapy

in Cancer Immunity and Immunotherapy

Siqi Zhao
Minjie Chen
Lingyu Hu
Xiaoping Li
Zhaofeng Gao
Fei Chen
Xiaoguang Wang
Song Zhengwei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1523190